Edwards Lifesciences Rest of World — Selling, general, and administrative expenses decreased by 31.1% to $48.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.0%, from $42.10M to $48.00M. Over 3 years (FY 2022 to FY 2025), Rest of World — Selling, general, and administrative expenses shows an upward trend with a 13.7% CAGR.
An increase may signal aggressive investment in market expansion, while a decrease could indicate cost-cutting measures or a shift toward more efficient digital sales models.
This metric tracks the operating expenses incurred to support sales, marketing, and administrative functions within the...
Comparable to 'Segment SG&A' or 'Regional Operating Expenses' reported by multinational healthcare companies.
ew_segment_rest_of_world_selling_general_and_administrative_expenses| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.65M | $35.65M | $35.65M | $35.65M | $41.60M | $41.60M | $41.60M | $41.60M | $41.40M | $46.60M | $43.10M | $50.30M | $42.10M | $48.30M | $49.50M | $69.70M | $48.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +16.7% | +0.0% | +0.0% | +0.0% | -0.5% | +12.6% | -7.5% | +16.7% | -16.3% | +14.7% | +2.5% | +40.8% | -31.1% |
| YoY Change | — | — | — | — | +16.7% | +16.7% | +16.7% | +16.7% | -0.5% | +12.0% | +3.6% | +20.9% | +1.7% | +3.6% | +14.8% | +38.6% | +14.0% |